Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about INCY
Recent news which mentions INCY
< Previous
1
2
3
4
5
6
7
Next >
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Tickers
ADVM
AFIB
AGTC
AKYA
Tags
APTX
HCWB
KLDO
From
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
Tickers
ABEO
ACER
AFIB
AGTC
Tags
XENE
DRRX
PBLA
From
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Tickers
ADTX
AFIB
AGTC
ARAV
Tags
TRVI
Market News
TLSA
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Tickers
ANIP
AVDL
BHC
CALT
Tags
ANIP
GMAB
Small Cap
From
Benzinga
More than a quarter of Nasdaq-100 stocks are in bear markets — Wall Street sees a buying opportunity
September 29, 2021
Tickers
AAPL
AMGN
AMZN
ATVI
Tags
JD
ZM
GOOGL
From
MarketWatch
Only 47 stocks in the S&P 500 have fallen over the past year — Wall Street predicts they will climb up to 54% in 12 months
September 28, 2021
Tickers
AKAM
AMGN
APD
ATO
Tags
LW
CHRW
WEC
From
MarketWatch
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
Tickers
AFIB
ALT
AMZN
APYX
Tags
EBS
GSK
News
From
Benzinga
Syndax Pharma, Incyte Ink Licensing Pact For Graft Vs. Host Disease Candidate
September 27, 2021
Tickers
INCY
SNDX
Tags
General
News
Briefs
From
Benzinga
Expert Ratings For Incyte
September 23, 2021
Tickers
INCY
Tags
Market News
Analyst Ratings
INCY
From
Benzinga
Incyte, Knight Therapeutics Ink Distribution Pact For Two Cancer Drugs In Latin America
September 23, 2021
Tickers
INCY
Tags
Market News
Diffuse Large B/Cell Lymphoma
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
September 23, 2021
Tickers
AMGN
ANNX
AOSL
ARGX
Tags
HUT
AVXL
MCG
From
Benzinga
BriaCell's Survival Story Could Mean a Better Chance of Survival for Women Suffering from Breast Cancer
September 23, 2021
Tickers
BCTX
INCY
Tags
BCTX
Market News
Benzinga
From
Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
Tickers
ABCL
ABSI
AFIB
ALZN
Tags
PSTX
HARP
ASND
From
Benzinga
10 Biggest Price Target Changes For Thursday
September 23, 2021
Tickers
FDX
INCY
KBH
LEN
Tags
KBH
Homebuilding
SPT
From
Benzinga
Back To Back FDA Approval For Incyte - This Time For Jakafi In GVHD
September 22, 2021
Tickers
INCY
Tags
Health Care
Biotech
graft versus host disease
From
Benzinga
Facebook, Incyte Fall Despite the Nasdaq's Strong Wednesday Start
September 22, 2021
Tickers
FB
INCY
Tags
INCY
FB
Market News
From
Motley Fool
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
Tickers
ABEO
ABSI
AFIB
AMAM
Tags
Small Cap
Biotech
Offerings
From
Benzinga
Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis
September 22, 2021
Tickers
INCY
Tags
Movers
INCY
News
From
Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
Tickers
ABSI
ADTX
AERI
AFIB
Tags
MESO
NVS
TXMD
From
Benzinga
Incyte's Pemazyre Wins Conditional Approval For Bile Duct Cancer In Canada
September 20, 2021
Tickers
INCY
Tags
FDA
Benzinga
Market News
From
Benzinga
Is AbbVie a Bad News Buy?
September 19, 2021
Tickers
ABBV
INCY
LLY
PFE
Tags
LLY
ABBV
PFE
From
Motley Fool
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
Tickers
AGTC
APRE
BMY
BNTX
Tags
News
CALT
AGTC
From
Benzinga
Price Over Earnings Overview: Incyte
September 14, 2021
Tickers
INCY
Tags
Earnings
News
INCY
From
Benzinga
FDA Hits JAK inhibitors With Heart Safety, Cancer Warnings: All You Need To Know
September 02, 2021
Tickers
ABBV
BMY
INCY
LLY
Tags
Market News
LLY
PFE
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
August 31, 2021
Tickers
ABBV
ASND
BGNE
BIIB
Tags
IBB
CARA
JAZZ
From
Benzinga
If you’ve got the stock market jitters, here are 20 companies in two defensive sectors
August 30, 2021
Tickers
ABC
AES
ANTM
BAX
Tags
ANTM
ZBH
MCK
From
MarketWatch
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Tickers
AGEN
ALKS
ALZN
BLFS
Tags
Top Stories
MOR
RPHM
From
Benzinga
Incyte - MorphoSys's Diffuse Large B-Cell Lymphoma Drug Wins European Approval
August 27, 2021
Tickers
INCY
MOR
Tags
Diffuse Large B/Cell Lyphoma
News
Briefs
From
Benzinga
These 20 ‘left behind’ stocks among the S&P 500 are expected to rise up to 59% over 12 months
August 26, 2021
Tickers
AAPL
AMZN
ATVI
BAX
Tags
PENN
FMC
RSP
From
MarketWatch
BriaCell, ImaginAb Join Forces To Assess Imaging Tech In Breast Cancer Trial
August 19, 2021
Tickers
BCTX
INCY
Tags
Benzinga
Trading Ideas
Market News
From
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.